Ty Pennington is raising awareness about a lung condition that often goes undiagnosed: bronchiectasis ...

Bronchiectasis is a progressive inflammatory lung condition. Symptoms resemble those of more common respiratory conditions.

Insmed has claimed the distinction of becoming the first company to get FDA approval for a treatment for chronic lung disease non-cystic fibrosis bronchiectasis (NCFB). The US regulator cleared DPP1 ...

The list of new medicines recommended for approval at the October meeting of the EMA's human medicines committee includes Brinsupri, the first treatment for serious chronic lung disease non-cystic ...

Phase 3b ENCORE data assess inhaled amikacin in MAC lung disease. Read more on efficacy, safety, and patient-reported ...

Ty Pennington exclusively opened up about his role as a caregiver for his mother, Yvonne, who was diagnosed with ...

Pennington said his mother has dealt with respiratory troubles his whole life. He remembers signs in his childhood home that said, "Caution: Lungs at work," and having to vacuum the walls to keep dust ...

For Barb, who has been living with bronchiectasis for nearly 20 years, shortness of breath and an uncontrollable cough were a ...

If you have non-cystic fibrosis bronchiectasis, you’re likely an expert on the “lung side” of the disease — the stubborn mucus, the nagging cough, and the constant threat of a flare-up. But by causing ...

Bronchiectasis is a chronic lung condition in which your airways, or bronchi, widen permanently and become scarred. It may cause a persistent cough, large daily production of mucus (sputum or phlegm), ...

The MHRA has licensed brensocatib (Brinsupri, Insmed Netherlands B.V.) as the first targeted therapy specifically for non- cystic fibrosis bronchiectasis (NCFB), offering a new treatment option for ...